All Pharmaceutical Microbiology articles – Page 4
-
NewsNanoparticles with antibacterial action shorten duration of tuberculosis treatment
A low-cost technology involving nanoparticles loaded with antibiotics and other antimicrobial compounds that can be used in multiple attacks on infections by the bacterium responsible for most cases of tuberculosis has been developed.
-
NewsResearchers reveal breakthrough in the development of drug for sleeping sickness
A novel way to attack the trypanosome parasite through its ribosome prevents the parasite from producing essential proteins, thus impairing its ability to survive.
-
NewsNew weapon against the super tough C diff bacteria shows promise
A researcher has demonstrated that a newer generation tetracycline antibiotic, Omadacycline, may be a promising tool in combating the resilient bacteria Clostridioides difficile (C diff), which causes an infection often picked up in hospitals.
-
NewsMedicinal plants offer hope for drug discovery and development against COVID-19
A new book offers insights into treating SARS-CoV-2 infections and respiratory problems, highlighting prospective drug discovery opportunities based on bioactive components from medicinal plants and herbal remedies.
-
NewsNew oral treatment reduces duration and symptoms of mild COVID-19
The treatment acts on the replication mechanism of SARS-CoV-2, the virus responsible for the disease, and reduces the severity and duration of some of the symptoms. In addition, it can be useful to treat the different mutations detected.
-
NewsDenovAI uses artificial intelligence to discover therapeutic antibodies
Kashif Sadiq has founded a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
-
NewsTeam-up of two new substances paves the way for new antibiotics
A new study shows how a combination of two new substances effectively kills methicillin-resistant Staphylococcus aureus (MRSA).
-
NewsNovel compounds promise success in the fight against tuberculosis and depression
Scientists have shown that a specific polyprenylated polycyclic acylphloroglucinol, PPAP53, is able to activate human macrophages to fight resistant tuberculosis bacteria without being toxic to the macrophages themselves.
-
OpinionCatch-22: the FDA, probiotics, and preterm infants
As the FDA issues warning letters about probiotic products sold for use in hospitalized preterm infants, families of babies threatened by necrotizing enterocolitis (NEC) now face a deadly Catch-22 situation.
-
NewsFungus-fighting protein could help overcome severe autoimmune disease and cancer
A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases such as irritable bowel disease (IBS) and type 1 diabetes.
-
NewsHIV drug could prevent coronaviruses, study finds
New research has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration.
-
NewsIce core proposal could revolutionise antibiotic discovery
A perspective article outlines a revolutionary approach to antibiotic discovery using ice cores, at a time when antimicrobial resistance (AMR) is projected to cause 10 million deaths per year by 2050.
-
NewsStudy reveals pain-relief pathways in disfiguring skin disease
For the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don’t hurt.
-
NewsResearchers develop material that reduces bacterial infection and speeds up bone healing
Researchers have developed a new surgical implant that has the potential to transform the treatment of complex bone infections.
-
News Nano-sized cell particles are promising tool in treating infectious diseases
In a new study, extracellular vesicles were found to inhibit the viral infection of COVID-19 and potentially other infectious diseases.
-
NewsLong-acting biologic has transmucosal transport properties that arrest Covid variants
Scientists report on a tailored ACE2 biologic, where ACE2 is fused to an engineered human albumin variant.
-
NewsResearchers create molecule to tackle antimicrobial resistance
Researchers at Maynooth University, working as part of an international team, have created a new molecule that could help in the fight against drug-resistant bacteria. Source: Ella Maru Studios Researchers have created a new molecule to fight drug-resistant bacteria Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi ...
-
NewsResearchers shed light on how one deadly pathogen makes its chemicals
Scientists have deciphered a previously unidentified cluster of genes responsible for producing sartorypyrones, a chemical made by the fungal pathogen Aspergillus fumigatus, whose family causes Aspergillosis in humans.
-
NewsResearchers develop new approaches in the fight against drug resistance in malaria
Researchers have combined the anti-malaria drug artemisinin with coumarin, which, like artemisinin, is also found in plants, and developed an auto-fluorescent compound from both bioactive substances.
-
NewsQuick and easy method tests antimicrobial susceptibility
Scientists have successfully developed an electrical impedance-based microfluidic platform that provides rapid and accurate AMR evaluation within an hour.
